Key result
Cardiac macrophages emerge as a therapeutic target to minimize cardiomyocyte death and treat HF.
Why the study?
Recent molecular studies have revealed significant complexity within cardiac macrophage populations, prompting a review of their origins, dynamics, cell surface markers, and functions in cardiac homeostasis and disease.
Answers are grounded in this paper and cite their sources.
Should not yet change HF practice; leaves open which macrophage functions to target therapeutically in trials.
Macrophages are integral components of cardiac tissue and exert profound effects on the healthy and diseased heart. Paradigm shifting studies using advanced molecular techniques have revealed significant complexity within these macrophage populations that reside in the heart. In this final of a 4-part review series covering the macrophage in cardiovascular disease, the authors review the origins, dynamics, cell surface markers, and respective functions of each cardiac macrophage subset identified to date, including in the specific scenarios of myocarditis and after myocardial infarction. Looking ahead, a deeper understanding of the diverse and often dichotomous functions of cardiac macrophages will be essential for the development of targeted therapies to mitigate injury and orchestrate recovery of the diseased heart. Moreover, as macrophages are critical for cardiac healing, they are an emerging focus for therapeutic strategies aimed at minimizing cardiomyocyte death, ameliorating pathological cardiac remodeling, and for treating heart failure and after myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Lavine et al. (2018) conducted a review in Cardiovascular disease, myocarditis, and myocardial infarction. Cardiac macrophages have diverse and dichotomous functions, making them an emerging focus for therapeutic strategies aimed at minimizing cardiomyocyte death and treating heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: